Insider · CIK 0001195881

KOBLISH ANTONY

Reports to the SEC for 2 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001195881

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-24	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,900 sh	$0.79	−$3,062.28	586,210
2026-02-23	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.6K sh	$0.77	−$8,909.346	741,985
2026-02-21	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.5K sh	$0.72	−$8,963.196	753,616
2026-02-20	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+176K sh	—	—	766,110
2026-02-20	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+261K sh	—	—	261,000
2025-03-31	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−384 sh	$1.22	−$468.48	590,110
2025-02-24	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,772 sh	$2.65	−$15.3K	590,494
2025-02-23	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.6K sh	$2.72	−$31.6K	596,266
2025-02-21	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+149K sh	—	—	607,897
2025-02-21	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+219K sh	—	—	219,000
2024-10-24	TELATELA Bio, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+88.9K sh	$2.25	+$200K	458,897
2024-03-31	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−385 sh	$5.67	−$2,182.95	370,009
2024-02-24	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,726 sh	$7.07	−$40.5K	370,394
2024-02-23	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+77.5K sh	—	—	381,134
2024-02-23	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+113K sh	—	—	113,200
2024-02-23	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,014 sh	$7.07	−$35.4K	376,120
2023-11-14	TELATELA Bio, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+11K sh	$4.54	+$50K	303,634
2023-03-31	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−385 sh	$10.64	−$4,096.4	292,634
2023-02-24	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,034 sh	$11.03	−$66.6K	293,019
2023-02-23	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+96.1K sh	—	—	96,100
2023-02-23	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+61.2K sh	—	—	299,053
2022-03-31	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−384 sh	$11.63	−$4,465.92	237,853
2022-02-24	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+46.5K sh	—	—	240,924
2022-02-24	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+79.5K sh	—	—	79,500
2022-02-24	TELATELA Bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,687 sh	$11.98	−$32.2K	238,237
2021-03-31	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+5,439 sh	—	—	194,424
2021-02-24	TELATELA Bio, Inc.A Award	Director, Chief Executive Officer	AAward	+34.9K sh	—	—	188,985
2021-02-24	TELATELA Bio, Inc. · Common Stock (right to buy)A Award	Director, Chief Executive Officer	AAward	+63.6K sh	—	—	63,600
2019-11-13	TELATELA Bio, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+7,277 sh	—	—	139,860
2019-11-13	TELATELA Bio, Inc. · Series B Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−351K sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−180K sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director, Chief Executive Officer	CConversion	−10.8K sh	—	—	10,775
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director, Chief Executive Officer	CConversion	−10.8K sh	—	—	0
2019-11-13	TELATELA Bio, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+14.2K sh	—	—	154,085
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−20K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−282K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−200K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−165K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−250K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−250K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−28K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−200K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−30K sh	—	—	0
2011-06-27	ORTHOVITA INCCOMMON STOCK OPTIONSD Disposition to Issuer	Director, PRESIDENT & CEO	DDisposition to Issuer	−100K sh	—	—	0
2011-06-24	ORTHOVITA INCU Disposition from Tender	Director, PRESIDENT & CEO	UDisposition from Tender	−167K sh	$3.85	−$642K	0
2011-03-03	ORTHOVITA INCCommon Stock OptionsA Award	Director, PRESIDENT & CEO	AAward	+250K sh	—	—	0
2011-03-03	ORTHOVITA INCCommon Stock OptionsA Award	Director, PRESIDENT & CEO	AAward	+250K sh	—	—	0
2010-03-04	ORTHOVITA INCCommon Stock OptionsA Award	Director, PRESIDENT & CEO	AAward	+300K sh	—	—	0
2009-03-03	ORTHOVITA INCStock Option (right to buy)A Award	Director, PRESIDENT & CEO	AAward	+165K sh	—	—	0
2007-09-14	ORTHOVITA INCP Purchase	Director, PRESIDENT & CEO	PPurchase	+5,000 sh	$2.49	+$12.5K	5,000

Recent filings

Accepted (ET)
Feb 244
KOBLISH ANTONY0001195881-26-000002
SEC(opens sec.gov)
Apr 24
KOBLISH ANTONY0001062993-25-006859
SEC(opens sec.gov)
Feb 254
KOBLISH ANTONY0001062993-25-003497
SEC(opens sec.gov)
Oct 244
KOBLISH ANTONY0001062993-24-017928
SEC(opens sec.gov)
Apr 24
KOBLISH ANTONY0001062993-24-007842
SEC(opens sec.gov)
Feb 274
KOBLISH ANTONY0001062993-24-004581
SEC(opens sec.gov)
Nov 144
KOBLISH ANTONY0001062993-23-020847
SEC(opens sec.gov)
Apr 44
KOBLISH ANTONY0001062993-23-008668
SEC(opens sec.gov)
Feb 274
KOBLISH ANTONY0001062993-23-005025
SEC(opens sec.gov)

Companies

Address

C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24

MALVERN, PA, 19355